Hikma Pharmaceuticals
About Hikma Pharmaceuticals
Certifications
Categories
-
PT
-
2018On CPHI since
-
2Certificates
-
5000+Employees
Company types
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Hikma Pharmaceuticals Resources (3)
-
News Hikma boosts US injectables business with $425 million deal for Custopharm
The acquisition will add 13 approved products and additional pipeline products -
News Partnership formed to develop and commercialise ready-to-use medicine
The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products. -
News Hikma and Civica Rx partnership to reduce generic drug shortages in the US
Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance